Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis

BACKGROUND: Osimertinib resistance limits the treatment of epidermal growth factor receptor-(EGFR)-mutated non-small-cell lung carcinoma (NSCLC). The mechanisms of osimertinib resistance need to be elucidated to determine alternative treatment strategies. This study explores the role of M2 type tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Xiaoying, Xie, Boxiong, Sun, Hui, Gu, Weiqing, Wang, Chunyan, Deng, Qinfang, Zhou, Songwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845243/
https://www.ncbi.nlm.nih.gov/pubmed/35168607
http://dx.doi.org/10.1186/s12935-022-02509-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845243/
https://www.ncbi.nlm.nih.gov/pubmed/35168607
http://dx.doi.org/10.1186/s12935-022-02509-x

Ejemplares similares